Active Pharmaceutical Ingredients

ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

PRODUCT SPECIFICATION THERAPEUTIC CATEGORY TECH PACK DMF APPROVAL
Sertraline HCI Form-I USP/EP CNS Available Available CEP/EU-WC
Sertraline HCI Form-II USP/EP CNS Available Available CEP/EU-WC
Fluoxetine USP/EP CNS Available Available --
Racecadotril IP/EP Anti Diarrhea Available Available CEP/EU-WC
Palonosetron HCI USP/IHS Anti Emetic Available Available USFDA/EU-WC
Silodosin IHS Benign Prostatic Hypertrophy Available Available EU-WC
Solifenacin Succinate EP/IHS Urinary Incontinence Available Available CEP/EU-WC
Tamsulosin HCI EP/USP Benign Prostatic Hypertrophy Available Available CEP/EU-WC
Tenofovir Disoproxil Fumarate USP/IHS Anti Retroviral Available Available EU-WC
Tenofovir Alafenamide Fumarate IHS Anti Retroviral Available Available EU-WC
Rupatadine Fumarate EP/IHS Anti Histamine Available Available CEP/EU-WC
Glucosamine HCI USP/EP Anti Arthritic Available Available EU-WC
Glucosamine Sulfate KCL USP Anti Arthritic Available Available EU-WC
Glucosamine Sulfate NaCI USP/EP Anti Arthritic Available Available EU-WC
Nitrofurantoin Monohydrate USP Anti microbial Available Available EU-WC
Nitrofurantoin Anhydrous USP/EP Anti microbial Available Available --
Nitrofurantoin Macrocrystal USP/EP Anti microbial Available Available --
Donepezil HCI IP/EP/USP/JP Dementia/Alzheimer's Disease Available Under Preparation --
Cetirizine HCI IP/EP/USP/JP Anti Histamine Under Preparation Under Preparation --

Active Pharmaceutical Ingredients (Under Development)

PRODUCT THERAPEUTIC CATEGORY
Cinacalcet Anti Hyperparathyroid
Felbamate Anti Convulsant
Zileuton Antiasthmatic
Pramiracetam CNS Stimulant & Nootropic Agent
Levocetirizine Di-HCl Anti Histamine

Disclaimer: Products covered by valid patents are not offered for commercial use. It is the responsibility of buyers to ensure transactions do not infringe any patent rights applicable.